JP2022028645A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022028645A5 JP2022028645A5 JP2021153771A JP2021153771A JP2022028645A5 JP 2022028645 A5 JP2022028645 A5 JP 2022028645A5 JP 2021153771 A JP2021153771 A JP 2021153771A JP 2021153771 A JP2021153771 A JP 2021153771A JP 2022028645 A5 JP2022028645 A5 JP 2022028645A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- antibody
- binding domain
- antigen binding
- subunit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18214994 | 2018-12-21 | ||
| EP18214994.8 | 2018-12-21 | ||
| JP2021534306A JP7061733B2 (ja) | 2018-12-21 | 2019-12-19 | Ｃｄ３に結合する抗体 |
| PCT/EP2019/086144 WO2020127619A1 (en) | 2018-12-21 | 2019-12-19 | Antibodies binding to cd3 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534306A Division JP7061733B2 (ja) | 2018-12-21 | 2019-12-19 | Ｃｄ３に結合する抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022028645A JP2022028645A (ja) | 2022-02-16 |
| JP2022028645A5 true JP2022028645A5 (https=) | 2022-12-27 |
| JP7653881B2 JP7653881B2 (ja) | 2025-03-31 |
Family
ID=78819196
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021126403A Active JP7090780B2 (ja) | 2018-12-21 | 2021-08-02 | Ｃｄ３に結合する抗体 |
| JP2021153771A Active JP7653881B2 (ja) | 2018-12-21 | 2021-09-22 | Ｃｄ３に結合する抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021126403A Active JP7090780B2 (ja) | 2018-12-21 | 2021-08-02 | Ｃｄ３に結合する抗体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP7090780B2 (https=) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2398829A2 (en) * | 2009-02-23 | 2011-12-28 | Glenmark Pharmaceuticals S.A. | Humanized antibodies that bind to cd19 and their uses |
| WO2014028748A1 (en) * | 2012-08-15 | 2014-02-20 | Irm Llc | Interleukin 2 antibodies and antibody complexes |
| MX375359B (es) * | 2013-02-26 | 2025-03-06 | Roche Glycart Ag | Moléculas biespecíficas de unión a antígeno activadoras de células t. |
| JP6464255B2 (ja) | 2014-08-04 | 2019-02-06 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | 二重特異性ｔ細胞活性化抗原結合分子 |
| RS61010B1 (sr) * | 2014-11-20 | 2020-11-30 | Hoffmann La Roche | Bispecifični antigen vezujući molekuli koji aktiviraju t ćelije protiv folr1 i cd3 |
| TWI744242B (zh) | 2015-07-31 | 2021-11-01 | 德商安美基研究（慕尼黑）公司 | Egfrviii及cd3抗體構築體 |
| WO2017055388A2 (en) | 2015-10-02 | 2017-04-06 | F. Hoffmann-La Roche Ag | Bispecific t cell activating antigen binding molecules |
| ES2897217T3 (es) | 2016-09-30 | 2022-02-28 | Hoffmann La Roche | Anticuerpos biespecíficos frente a p95HER2 |
-
2021
- 2021-08-02 JP JP2021126403A patent/JP7090780B2/ja active Active
- 2021-09-22 JP JP2021153771A patent/JP7653881B2/ja active Active